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Abstract
Pain Body Maps are promising tools for patients with advanced cancer. We brieﬂy present Computerised Pain Body Maps from the
literature, and contrast them with our own CPBM speciﬁcally designed for this patient group. Furthermore, we ponder the fact that
current CPBMs do not really oﬀer any more functionality than the paper PBMs, but show how a fully-functioning CPBM system
is a prerequisite to many innovations in pain management.
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1. Introduction
A Computerised Pain Body Map (CPBM) is a digital version of a pain body map, a drawing of the human body
that can be used by a patient to mark pain (”this is where it hurts”). A number of CPBMs have been proposed in
recent years, but none of them seem to have documented very well how they have been developed or how they have
involved patients and clinicians in the process, and none of them have been developed for patients with advanced
cancer disease.
In this paper we describe the development of a new CPBM for patients with advanced cancer. Our CPBM has
explicitly involved patients and clinicians in an iterative manner, and tests indicate that it is perceived as useful by
both target groups. We show that although the CPBM does not strictly speaking oﬀer any signiﬁcantly new features
when compared to a paper PBM, a functioning CPBM system is a prerequisite to a multitude of new functionality for
managing pain in this patient group.
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Fig. 1. The Sick Du¨rer.
The remainder of this paper is structured as follows: In Section 2 we present background information on pain body
maps used in clinical practice. We present our own CPBM in Section 3, and outline new possibilities in Section 4. We
discuss our ﬁndings in Section 5, and oﬀer our conclusions in Section 6.
2. Background
Pain is a subjective experience, and is one of the most common reasons for patients to see a doctor. During
the conversation with the physician, the patient is faced with the challenge of explaining the details about the pain
experience; such as where it hurts, the quality of pain, temporal pattern and pain interference. This detailed description
depends on the patient’s knowledge of anatomy as well as ability to produce an accurate description of the painful
experience. This conversation is partly challenged by the lack of a common language to describe the pain. Thus, a
precise pain drawing may aid this conversation substantially.
2.1. Paper Pain Body Maps
Pain Body Maps (PBMs) have been used for decades as a diagnostic aid to pain management. The 16th century
German painter Albrecht Du¨rer may have been the ﬁrst to employ a drawing of the human body to indicate location
of pain when he in a letter made a self portrait (see Fig. 1) annotated by a yellow mark and the text “the yellow spot
shows where I hurt” (paraphrased)1.
In more recent times, PBMs have been a part of the most frequently used questionnaires for assessing pain; the
Edmonton Symptom Assessment System (ESAS)2 and the Brief Pain Inventory (BPI)3. PBMs have been validated
for use with most patients, and have also shown good inter-rater reliability for healthcare professionals4.
For clinical decision making, information on pain location, intensity, distribution and temporal factors may provide
important information to the physician. All this information can be presented and extracted from a pain drawing.
2.2. Computerised Pain Body Maps
Table 1 lists diﬀerent projects involving development and/or testing of CPBMs. A general observation is that most
of the studies are qualitative exploratory studies. Only one study has used a quantitative study design5. From this we
can conclude that the concept is not fully explored, and a consensus to design has not been established.
None of the other studies in Table 1 have described their test participants properly in terms of how the disease aﬀects
their abilities to interact with the tool. Two studies have included cancer patients6,8. Additionally, only one study10
has explicitly reported development involving actual patients. However, through testing in the qualitative studies,
interaction problems related to patients’ disability or design ﬂaws have been reported. One study recommends natural
drawing behaviour based on test results7. This is also the implicit strategy of the other studies.
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Table 1. Existing CPBMs from the literature.
Author Aim Study design Projection of the
CPBM/platform
Development
method
Population Outcome
Wilkie et al. 6 Improvement of
eﬃciency of pain
management
Feasibility test-
ing, Quantitative
and qualitative
data (ﬁeld notes)
2-D, PC N/A Cancer patients
and members of
the public
Conﬁrmed
usability but
improvements
were needed
Jang et al. 7 Visual encoding
of pain, eﬃcacy
assessment, vali-
dation of design
decision
Exploratory
design study
2-D, PC User-centered
testing
Students and
University em-
ployees, Physi-
cians, nurses,
pharmacist
Support nat-
ural drawing
behaviour, Con-
tent perceived
more detailed
compared to text
Jud et al. 8 Describe spatial
distribution of
paraesthesia
Exploratory
study
2-D, PC N/A Breast cancer sur-
vivors
Deﬁned distribu-
tion of sensory
symptoms
Lalloo et al. 9 Dev. tool for vi-
sual supplemen-
tation of informa-
tion about loca-
tion, intensity and
quality of pain
Exploratory
study
2-D No information
about the original
development,
User-centred
testing
Chronic pain pa-
tients from a sup-
port group
Conﬁrmed
usability and per-
ceived usefulness
Jamison et al. 5 Evaluate tempo-
ral reliability
Pilot testing
Comparative
study
3-D N/A Stable chronic
non-cancer pain
Temporal stable
pain marking
in x, y and z
dimensions
(1) Serif et al. 10
(2) Ghinea et
al. 11
(3) Spyridonis
and Ghinea 12
(4) Grønli et al. 13
(1) Dev. system
for monitoring
low back pain
(2) Reﬁne the (1)
3-D system
(3) Compare
subj. and objec-
tive measures for
pain, pilot testing
(4) Usability
investigation of a
PBM
(1,2,4) Ex-
ploratory study
(3) Comparative
study (4) Pilot
testing
3-D, Personal
Digital Assistant
(PDA), Android
(1) User centred
design study
(2,4) No user-
involvement
reported in devel-
opment
(3) N/A
Wheel-chair
users and physi-
cians
(1,2) PoC
(1) Interaction
problems
(2) Scalability
and higher dis-
crimination of
response
(3) Association
between pain
marking and
pressure point
(4) Positive user
experience
Our solution 14 Develop a CPBM
usable by most
patients with ad-
vanced cancer
Exploratory
study in a clinical
setting
2-D, tablet User-centered
design
Patients with
advanced cancer
and physicians
Conﬁrmed usa-
bility for patients
with advanced
cancer
Implementation of diﬀerent pain dimensions other than location, has been considered in all but the study from Jud
et al. 8. The diﬀerent pain dimensions implemented were location (distribution) and intensity; additionally, Jamison et
al. included an option for annotating superﬁcial or deep pain5.
Both PC and mobile devices have been used in the diﬀerent studies. However, none of the mobile platforms
has reported hand-eye coordination diﬃculties. From the body of evidence from digital development and testing of
CPBM, natural drawing behaviour is recommended. Most studies report interaction problems, but there is limited
evidence to the exact problems and when they occurred. None of the studies above has reported including patients
with cognitive impairment, and there is limited evidence for best practice design to customise the CPBM to patients
severely burdened by disease.
Only one study reported on cancer patients, but their qualitative approach provided limited data. Only two studies
reported information on the user interaction during development of the tool10,7. The test participants were recruited
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from Amazon Mechanical Turk in Jang et al. 7, whereas Serif et al. 10 reported on wheelchair users’ interaction with
their tool. Both reports were based on self-report by a survey.
All studies haves reported from diﬀerent projections of the body, except from the study reports from Serif et al.,
Ghinea et al., Spyridonis et al., and Grønli et al., which seem to be reports on one evolving product. The diﬀerent pro-
jections in all the diﬀerent study reports were a result of the intention to provide more accurate pain drawings. Based
on the current evidence, groups of people with special traits such as cognitively disabled or breast cancer patients with
axillar pain need more detailed anatomical PBMs, as described in the studies by Jud et al. 8 and Bromley et al. 15. En-
largement of the body image was provided in the study by Bromley et al. 15, probably intended to reduce requirements
to dexterity. Jud et al. speciﬁcally displayed the axillar area on the body image where frequently paresthesia after
breast cancer treatment was perceived8. However, extensive searches have not yielded recommendations on the level
of detailed anatomical drawings which provides most beneﬁts to patients when marking their pain, and to clinicians
when interpreting the drawings. Thus, there seems to be a lack of consensus on projections and the level of accuracy
needed for a tool like this. This was also commented on in an editorial in Pain 36 years ago16.
The accuracy of the spatial pain drawing has been given very limited focus in research. However, a more detailed
pain drawing might be associated with a higher accuracy. One study reports on more detailed pain drawings by
patients as a result of training and proper instructions17. Training and instructions seem to be beneﬁcial also for
clinicians evaluating the pain drawings.
Visualisation of subjective pain information is an important concept in all the studies presented in Table 1. Espe-
cially, Lalloo et al. 9 and Jang et al. 7 promote the advantages of using a visual image to reduce complexity of a pain
description.
A common denominator among all CPBM papers was inconsistencies in the presentations of the computerized
tools and the descriptions of interaction with the tool, the study aims and choice of study method. Most studies aimed
to explore usability of their computer program in diﬀerent patient groups. However, this was performed without
describing the traits characteristics of the users. One of the reports pointed at the speciﬁc usability needs of wheelchair
users with higher level disability in their arms without further description13.
From the patients’ self-report data in these studies, visual communication of pain was preferred to verbal descrip-
tions7,18. Additionally, patients perceived sharing of data as useful9. The reports from clinicians, although they were
in a very limited number, were positive and enthusiastic with respect to using digital assessment and visual commu-
nication in the interaction with their patients7,12.
Most studies consider the use of CPBMs promising for future clinical practice and patient-clinician communica-
tion; however, the methods, reports, patient groups and tools are too fragmented and inconsistently reported to provide
satisfactory empirical data. Also, the research reports from the CPBM studies seem to demonstrate limited clinical
collaboration in planning, development and evaluation of results. Surprisingly, only one of these studies7 seems to
have considered the challenge of transferring the concept of a paper PBM to a computerized version.
The studies in Table 1 span from 2003 to 2015, but generally seem to cover the same ground, and it thus appears
that there has been little real progress in the past decade. Although the programs and platforms have evolved, there is
no evidence on how this evolution has inﬂuenced clinical practice.
The current evidence, exploring this ﬁeld of research, both from the medical and the technological side, could
potentially provide useful contributions to future pain management. The medical studies have mostly been performed
as comparative studies providing evidence for a limited research question. How this evidence could be used to reﬁne
the concept of pain assessment with a PBM has been given very little focus. In the information technology ﬁeld, the
studies can be characterized as exploratory, with a wide view on the concept of visualizing pain, and limited detailed
evidence on development method, user groups, domains to assess, reliability and validity. This implies that a joining
of forces between the clinical and the technological side is necessary for moving forward in this ﬁeld.
3. A CPBM for Patients with Advanced Cancer
Patients with advanced cancer is a diverse group, with diﬀerent life expectancies, symptom burdens and need of
care. Evidence has shown a high pain prevalence which have substantial impact on Quality-of-Life, dependent on
severity as well as inﬂuence of symptoms interfering with pain. Thus, ability to understand the pain problem is vital
to enable tailoring the pain management. There are diﬀerent pain domains that are important for treatment, one of
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Fig. 2. Three Versions of a CPBM for Patients with Advanced Cancer.
which is where the pain is located. To improve the patients’ ability to communicate this problem to the clinicians, a
project was set out to develop a CPBM for patients with advanced cancer19.
We have developed14 a CPBM speciﬁcally for patients with advanced cancer (Fig. 2). The tablet-based CPBM is
complemented with a web-based interface for clinicians, where historical ﬁlled-out pain body maps can be retrieved.
The CPBM has been developed iteratively in three major versions, as described in the following.
3.1. Version 1
The ﬁrst platform was a laptop computer and a CPBM program developed using a waterfall development method.
The 2D pain drawing program used short written instructions and simple functions to prompt patients to mark pain
and select a pain intensity. The ﬁrst version19 was tested in a large international patient population of patients with
advanced cancer. The result showed good feasibility and acceptability of a computerized tool among these patients.
A comparative study set out to investigate the reliability of the CPBM compared to a paper version of the pain body
map. The results showed a lower rate of concordance between the paper version and the CPBM than what was
acceptable (85%). This indicated a need to re-investigate the design the CPBM. In a separate usability study we were
able to identify some problem areas related to advanced cancer and interaction with a computer platform. The results
showed patient limitations with the platform, screen quality, dexterity and program features. All problem areas were
implemented in the primary requirements to a new version of a CPBM.
3.2. Version 2
Based on experiences from the ﬁrst version, a new design approach was made where patients were deﬁned as users
in a user centered development process. Through several iterations we developed a tablet based platform of a CPBM14
based on natural drawing behaviour for deﬁning the pain location and the selection of pain intensity from a numerical
rating scale (NRS) from 1-10, with 10 indicating worst pain imaginable. Each number represented a colour that would
visualise diﬀerent pain intensity when marked on the body.
From our testing we were able to tailor this platform to the sickest and frailest of the patients. This approach made
it necessary to reduce complexity, speed and prompts from the computer program until the features were very similar
to a paper tool. However there were identiﬁed a few who were not able to make the pain drawings due to diﬀerent
cognitive problems (such as confusion), sedation, or simply being too physically impaired; all of which are common
problems at the end of a disease trajectory.
3.3. Version 3
Pain among advanced cancer patients have diﬀerent etiology and diﬀerent pain types require diﬀerent pain man-
agement approach. Thus, identiﬁcation of etiology is important. From clinical studies we have learned that a large
number of patients treated for cancer are suﬀering from a type of pain deﬁned as neuropathic pain, caused by a lesion
or disease of the peripheral nervous system20. This means that the pain arises from the nervous system, and has a more
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distinct pattern dependent on cause and location21,22. Neuropathic pain can also be a side eﬀect of cancer treatment,
and with increased longevity of terminal cancer patients, an increased prevalence of this pain type must be expected.
Version 3 implemented enhanced possibilities of visual identiﬁcation of suspected neuropathic pain patterns, en-
abling clinicians to recognise the symptoms earlier. Furthermore, this version provided a web-based clinician interface
for access to stored pain maps. Patients opined that use of such a system enabled them to better communicate their
pain to family and friends, as well as improving the communication to the health care providers.
Treating neuropathic pain is demanding for health care providers, and requires special expertise. The CPBM
made is possible to share pain data originating directly from the patient with colleagues and oﬀ-site experts, without
requiring the ﬁrst-line clinician to ﬁrst interpret the patient’s information. The new system provides a very simple
interface that even the frailest and sickest could interact with, but the system also provides visualisation of the most
important information for the clinicians in order to manage the pain. The system could be used by patients from the
very beginning of the disease trajectory until the end. The platform used was easily accessible and also aﬀordable for
patients, and could be used either at home or in an institution. This enabled longitudinal pain surveillance, which is of
paramount importance to treat pain properly as well as early detection of changes in pain severity or new pains. This
feature was considered a new and very much needed functionality by the clinicians in this study.
4. New Directions
Through the development of our CPBM, we have come to realize that it strictly speaking does not oﬀer any new
features when compared to the paper PBM; it would be entirely possible to hand patients paper PBMs, have them ﬁll
them in using colour pencils (as in the CPBM mockup14), scan the ﬁnished PBM, and store it in a retrieval system.
Currently, the computerised version is primarily a little more convenient to use.
However, when a CPBM system (with web-based backend) is available for use, it opens up a myriad of other
possibilities which a paper PBM cannot oﬀer. A CPBM allows exact recording of the marked pain areas, and is
easier to share, store and retrieve. The CPBM implements speciﬁcation of both severity and location, which can
assist identiﬁcation of the cause of the pain. Better identiﬁcation of pain causes can also contribute to better treatment
options.
4.1. Longitudinal Data
A CPBM in systematic use will enable longitudinal pain measurement for larger populations, diﬀerent diseases,
diﬀerent interventions and diﬀerent practitioners. When used in larger populations, more pain data is generated, and
this will enable a better diﬀerentiation between diﬀerent pain patterns. For a given patient, a longitudinal approach
allows quicker recognition of symptoms, enabling timely intervention and treatment, possibly with prevention of
fulminant disease outbreak.
On a more general level, the system could also provide the ability to evaluate quality of clinical care by transparency
of archive data, which can be used for intra-organisational learning, which in turn could lead to further improvements
in clinical practice.
4.2. New Visualisations
Pain can have diﬀerent qualities such as stinging, burning, prickling, etc., but sensations can also be transmitted
quickly or slowly depending on the nerves involved. The nerve ﬁbers have diﬀerent qualities, and can be aﬀected dif-
ferently by disease or treatment side eﬀects. Sensory changes can be perceived as pain, but also as reduced sensibility
(e.g., numbness) or enhanced sensibility. Digital pain data will enable visualisation of all these qualities, speciﬁcation
of which areas they occur in, and how they develop over time.
Furthermore, if patients are capable of accurately describing the extension of their pain, 3-D pain visualisation can
be combined with Computer Tomography or Magnetic Resonance imaging to better understand the subjective pain
experience and contrast it with objective ﬁndings. More research is needed to verify how accurate patients are able to
specify their pain, as pain is sometimes vague, but other times very distinct and speciﬁc. Sensations such as numbness
may be vague by nature. On the other hand, being able to specify an area of “diﬀuse pain” my be a diagnostic clue as
well.
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The most important aspect of visualisation is to arrive at a design that most patients are able to understand and
draw, and the digital representation will then allow rendering in any fashion that will help physicians (or machines) to
interpret the results.
Using multimedia to present abstract information can be further exploited to give targeted feedback to patients
to achieve a learning eﬀect, and teaching patients more about their disease can be a step toward increased patient
empowerment which is an element that can contribute to more patient-centered care.
4.3. Interpretation of Markings
Further research can also lead to innovation opportunities such as pattern recognition research, which can identify
diﬀerent pain types. The current version of the CPBM can be used for both nociceptive and neuropathic pain, e.g., pain
from internal organs, skin and the nervous system. This kind of pain can have diﬀerent pain patterns depending on the
kind of underlying disease, e.g., disease in the gall bladder can elicit pain in the right shoulder, and diabetic neuropathy
can give the sensation of walking on pillows. By recognising these and other pain patterns (and potentially identifying
new patterns), diseases may be detected earlier by patients and physicians, and this data can be incorporated in
algorithms for decision support in clinical practice.
This is particularly relevant in the case of new cancer development, where identiﬁcation of new pain areas can
be linked to dissemination patterns of speciﬁc cancer diseases, and thus automatically give a signal of metastasizing
cancer.
4.4. Extension of Pain as Indicator of Treatment Response
Pain severity is currently a very imprecise and subjective measure, and is diﬃcult to determine exactly. Fallon et
al. 23 argue that treatment response to neuropathic pain can be measured accurately by the extension of pain. In a
CPBM this can be measured quickly, accurately and automatically, also in a longitudinal fashion. Pain extension can
be seen as a more objective measure, and easier to decide that the more abstract “severity”. However, there is currently
no consensus on this topic, so further research is necessary to determine whether this can be a workable approach.
5. Discussion
The initial idea for this project was to improve a paper assessment tool and digitize it for a fast growing patient
population in need of better systems for optimizing care. The current system is just scratching the surface of the
opportunities that lie ahead.
Most patients seek medical help due to subjective symptoms such as pain. The symptoms are often diﬀuse, and de-
scribing them with words often make everything more diﬀuse. Pain documentation using a CPBM can both contribute
to improved symptom communication, and lead to a quicker and more distinct assessment of the patient’s ailments.
As our project has shown, patient involvement and especially patients severely burdened by disease pose high re-
quirements on ergonomics as well as options for interactions. Thus, it has to be the responsibility of the development
team to provide clinical tools that provide reliable responses by most patients. In that respect our empirical work
has revealed information about patient limitations and tool strengths that very few of the existing pain assessment
tools (Table 1) have displayed, and use in clinical studies could therefore provide improved understanding of pain
sensations among patients with advanced cancer.
An improved understanding of subjective sensations is helpful not only for cancer patients, but also for many other
patient groups. Advances in technology in this ﬁeld open possibilities in the medical domain, and evidence in the
medical domain opens up for further technological research. Thus, research and further development in this ﬁeld
require an interdisciplinary collaboration and understanding.
6. Conclusion
We have presented a CPBM developed with the involvement of patients with advanced cancer and clinicians that
it is perceived as useful by both target groups. We have shown that although the CPBM does not strictly speaking
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oﬀer any signiﬁcantly new features when compared to a paper PBM, a functioning CPBM system is a prerequisite to
a multitude of new functionality for managing pain in this patient group.
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